Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaishali M Patil

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|July 5, 2022
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike proteinSaroj Verma, Vaishali M Patil, Manish K Gupta
Current Drug Discovery Technologies|October 11, 2016
GENIUS In Silico Screening Technology for HCV Drug DiscoveryVaishali M Patil, Neeraj Masand, Satya P Gupta
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 12, 2010
A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysisS P Gupta, S Samanta, Vaishali M Patil
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2020
Molecular Processes Exploited as Drug Targets for Cancer ChemotherapySatya P Gupta, Anjana Sharma, Vaishali M Patil
Current Topics in Medicinal Chemistry|November 21, 2015
HCV Inhibitors: Role of Compounds from Botanical SourcesVaishali M Patil, Neeraj Masand, Satya Prakash Gupta
Journal of the Egyptian National Cancer Institute|November 8, 2021
Non-cancer to anti-cancer: investigation of human ether-a-go-go-related gene potassium channel inhibitors as potential therapeuticsVaishali M Patil, Anand Gaurav, Priyanka Garg, et al.
Bioinformation|October 27, 2010
A QSAR study on some series of anti-hepatitis B virus (HBV) agentsPreet K Arora, Vaishali M Patil, Satya P Gupta
Current Drug Discovery Technologies|January 29, 2019
Cinnamaldehyde Analogs: Docking Based Optimization, COX-2 Inhibitory In Vivo and In Vitro StudiesVaishali M Patil, Preeti Anand, Monika Bhardwaj, et al.
Chemical Biology & Drug Design|September 14, 2021
Chromones: Privileged scaffold in anticancer drug discoveryVaishali M Patil, Neeraj Masand, Saroj Verma, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 12, 2012
3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitorsVaishali M Patil, Satya Prakash Gupta, Subeer Samanta, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|July 5, 2022
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike proteinSaroj Verma, Vaishali M Patil, Manish K Gupta
Current Drug Discovery Technologies|October 11, 2016
GENIUS In Silico Screening Technology for HCV Drug DiscoveryVaishali M Patil, Neeraj Masand, Satya P Gupta
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 12, 2010
A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysisS P Gupta, S Samanta, Vaishali M Patil
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2020
Molecular Processes Exploited as Drug Targets for Cancer ChemotherapySatya P Gupta, Anjana Sharma, Vaishali M Patil
Current Topics in Medicinal Chemistry|November 21, 2015
HCV Inhibitors: Role of Compounds from Botanical SourcesVaishali M Patil, Neeraj Masand, Satya Prakash Gupta
Journal of the Egyptian National Cancer Institute|November 8, 2021
Non-cancer to anti-cancer: investigation of human ether-a-go-go-related gene potassium channel inhibitors as potential therapeuticsVaishali M Patil, Anand Gaurav, Priyanka Garg, et al.
Bioinformation|October 27, 2010
A QSAR study on some series of anti-hepatitis B virus (HBV) agentsPreet K Arora, Vaishali M Patil, Satya P Gupta
Current Drug Discovery Technologies|January 29, 2019
Cinnamaldehyde Analogs: Docking Based Optimization, COX-2 Inhibitory In Vivo and In Vitro StudiesVaishali M Patil, Preeti Anand, Monika Bhardwaj, et al.
Chemical Biology & Drug Design|September 14, 2021
Chromones: Privileged scaffold in anticancer drug discoveryVaishali M Patil, Neeraj Masand, Saroj Verma, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 12, 2012
3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitorsVaishali M Patil, Satya Prakash Gupta, Subeer Samanta, et al.
Pageof 5